









Markets
/
Stocks
/
nasdaq-zbio
/

Zenas Biopharma Inc

ZBIO

19.460USD

+0.395+2.07%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

819.05MMarket Cap

LossP/E TTM



Zenas Biopharma Inc

19.460

+0.395+2.07%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-34.83%-41.74M

-93.96%-37.05M

-150.35%-38.55M

-197.53%-31.06M

-48.04%-30.96M

26.71%-19.10M

10.08%-15.40M

--31.85M

---20.91M

---26.06M

---17.13M

Net income from continuing operations

-37.51%-52.22M

-20.77%-33.57M

-113.95%-52.60M

-208.43%-38.61M

-30.74%-37.98M

-45.57%-27.80M

-29.45%-24.59M

--35.61M

---29.05M

---19.10M

---18.99M

Operating gains losses

-65.71%12.00K

-30.30%23.00K

10.00%33.00K

38.46%36.00K

20.69%35.00K

17.86%33.00K

20.00%30.00K

--26.00K

--29.00K

--28.00K

--25.00K

Other non-cash items

-628.78%-735.00K

-185.53%-136.00K

-321.94%-344.00K

-27.75%125.00K

-98.64%139.00K

-16.75%159.00K

-49.84%155.00K

--173.00K

--10.21M

--191.00K

--309.00K

Change in working capital

0.04%5.16M

-229.03%-8.86M

17.17%8.87M

191.54%4.54M

286.14%5.16M

187.21%6.87M

508.28%7.57M

---4.96M

---2.77M

---7.87M

--1.24M

-Change in prepaid expenses

137.23%1.16M

-119.75%-353.00K

-698.97%-8.18M

159.33%1.79M

-286.78%-3.10M

299.66%1.79M

100.74%1.36M

---3.02M

---802.00K

---895.00K

--680.00K

-Change in other current liabilities

----

---530.00K

---970.00K

--1.50M

----

--0.00

----

Cash from non-recurring investing activities

Cash from operating activities

-34.83%-41.74M

-93.96%-37.05M

-150.35%-38.55M

-197.53%-31.06M

-48.04%-30.96M

26.71%-19.10M

10.08%-15.40M

--31.85M

---20.91M

---26.06M

---17.13M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

-18.18%18.00K

335.29%74.00K

--0.00

--35.00K

--22.00K

-98.42%17.00K

--0.00

--1.07M

Capital expenditures

-100.00%0.00

-18.18%18.00K

335.29%74.00K

--0.00

--35.00K

--22.00K

-98.42%17.00K

--0.00

--1.07M

Net cash flow from disposal of fixed assets

-100.00%0.00

-18.18%18.00K

335.29%74.00K

--0.00

--35.00K

--22.00K

-77.03%17.00K

--0.00

--74.00K

Net cash flow from intangible asset transactions

----

-100.00%0.00

----

--1.00M

Net cash flow from investment products

---112.29M

---86.26M

---3.66M

---26.76M

----

Cash from non-current investing activities

Net cash flow from investing activities

-320731.43%-112.29M

-392054.55%-86.27M

-21870.59%-3.73M

---26.76M

---35.00K

---22.00K

98.42%-17.00K

--0.00

---1.07M

Financing cash flow

Cash flow from continuous financing activities

-99.03%1.72M

116.12%99.00K

3606.00%1.85M

1069.90%233.98M

1615709.09%177.74M

-1216.36%-614.00K

-99.92%50.00K

--20.00M

--11.00K

--55.00K

--59.39M

Net cash flow from debt Issuance/repayment

----

-100.00%0.00

----

--0.00

--20.00M

----

--0.00

Net cash flow from common stock issuance/repurchase

----

--6.25M

--234.39M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

--178.38M

----

--0.00

----

--59.39M

Proceeds from stock option exercised by employees

1288.71%1.72M

135.71%99.00K

54.00%77.00K

--32.00K

1027.27%124.00K

-23.64%42.00K

--50.00K

--0.00

--11.00K

--55.00K

--0.00

Net cash flow from other financing activities

----

---4.47M

---439.00K

---766.00K

---656.00K

----

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-99.03%1.72M

116.12%99.00K

3606.00%1.85M

1069.90%233.98M

1615709.09%177.74M

-1216.36%-614.00K

-99.92%50.00K

--20.00M

--11.00K

--55.00K

--59.39M

Net cash flow

Beginning cash balance

427.79%196.55M

461.68%319.83M

397.43%360.13M

795.60%184.02M

-9.79%37.24M

-15.38%56.94M

177.52%72.40M

--20.55M

--41.28M

--67.30M

--26.09M

Current period cash flow changes

-203.93%-152.55M

-525.71%-123.28M

-160.74%-40.30M

239.65%176.11M

807.87%146.78M

24.26%-19.70M

-137.50%-15.45M

--51.85M

---20.73M

---26.01M

--41.21M

Effect of exchange rate changes

-837.50%-236.00K

-244.44%-52.00K

262.07%141.00K

-1400.00%-52.00K

-80.72%32.00K

820.00%36.00K

-583.33%-87.00K

--4.00K

--166.00K

---5.00K

--18.00K

Ending cash balance

-76.09%44.01M

427.80%196.55M

461.67%319.83M

397.43%360.13M

795.60%184.02M

-9.79%37.24M

-15.38%56.94M

--72.40M

--20.55M

--41.28M

--67.30M

Free cash flow

-34.68%-41.74M

-93.83%-37.07M

-150.55%-38.63M

-197.53%-31.06M

-48.21%-30.99M

26.62%-19.12M

15.30%-15.42M

--31.85M

---20.91M

---26.06M

---18.20M

Currency unit

USD

Audit opinions

KeyAI

